(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -2.67%4.43B | -5.66%18.17B | -7.72%13.66B | -7.93%9.16B | 0.04%4.55B | 14.71%19.26B | 15.48%14.8B | 18.61%9.95B | 18.40%4.55B | 27.03%16.79B |
Operating income | -2.67%4.43B | -5.66%18.17B | -7.72%13.66B | -7.93%9.16B | 0.04%4.55B | 14.71%19.26B | 15.48%14.8B | 18.61%9.95B | 18.40%4.55B | 27.03%16.79B |
Operating expenses | 3.71%-2.74B | 11.39%-11.7B | 12.95%-8.74B | 14.75%-5.78B | 5.15%-2.85B | -15.20%-13.21B | -17.03%-10.04B | -24.23%-6.78B | -25.42%-3B | -35.06%-11.46B |
Gross profit | -0.93%1.69B | 6.85%6.47B | 3.30%4.92B | 6.68%3.38B | 10.08%1.71B | 13.66%6.06B | 12.35%4.76B | 8.13%3.16B | 6.83%1.55B | 12.62%5.33B |
Selling expenses | 57.55%-14.61M | 28.80%-76.14M | -33.40%-99.02M | -172.07%-69.07M | -196.21%-34.43M | -93.07%-106.94M | -72.92%-74.23M | 7.66%-25.39M | -2.96%-11.62M | -36.36%-55.39M |
Administrative expenses | 3.90%-229.59M | -8.91%-1.04B | 4.49%-691.7M | -9.90%-496.91M | -37.05%-238.92M | -3.77%-952.09M | -18.83%-724.22M | -9.59%-452.14M | 5.01%-174.32M | -43.97%-917.48M |
Research and development expenses | -9.61%-23.08M | 5.69%-104.94M | 9.38%-80.61M | 9.22%-50.75M | -44.11%-21.06M | -34.34%-111.27M | -166.19%-88.95M | -363.94%-55.91M | -153.97%-14.61M | -310.47%-82.83M |
Profit from asset sales | 913.43%18.51M | 0.92%15.34M | 1,018.40%10.19M | 259.63%4.91M | 76.84%1.83M | -54.02%15.2M | -89.64%910.91K | -60.71%1.36M | 189.37%1.03M | 86.50%33.06M |
Revaluation surplus | --903.3K | -106.60%-560.51K | -124.04%-1.02M | -211.85%-1.02M | ---- | -57.87%8.49M | -62.44%4.24M | -105.74%-326.55K | 112.46%472.3K | 817.56%20.15M |
-Changes in the fair value of other assets | --903.3K | -106.60%-560.51K | -124.04%-1.02M | -211.85%-1.02M | ---- | -57.87%8.49M | -62.44%4.24M | -105.74%-326.55K | 112.46%472.3K | 817.56%20.15M |
Impairment and provision | -152.14%-6.96M | 207.37%26.16M | 254.18%62.8M | 250.12%58.69M | 137.67%13.35M | 48.09%-24.36M | -55.63%-40.73M | 16.73%-39.1M | 29.79%-35.44M | 41.85%-46.94M |
-Other impairment is provision | -152.14%-6.96M | 207.37%26.16M | 254.18%62.8M | 250.12%58.69M | 137.67%13.35M | 48.09%-24.36M | -55.63%-40.73M | 16.73%-39.1M | 29.79%-35.44M | 41.85%-46.94M |
Special items of operating profit | 2.92%440.87M | 4.94%1.72B | 6.20%1.28B | 6.87%841.22M | 13.63%428.36M | 2.12%1.64B | 10.52%1.2B | -1.05%787.17M | -2.14%376.98M | -2.31%1.6B |
Operating profit | 0.82%1.83B | 7.61%6.86B | 7.12%5.28B | 8.38%3.58B | 9.51%1.82B | 11.20%6.38B | 9.02%4.93B | 4.75%3.31B | 7.23%1.66B | 4.11%5.73B |
Financing cost | 76.09%-10.69M | -159.18%-108.78M | -153.94%-89.46M | -142.51%-52.77M | -227.48%-44.71M | 83.71%183.82M | 124.90%165.86M | 194.52%124.14M | 54.01%35.07M | 647.81%100.06M |
Special items of earning before tax | -145.64%-1.56M | 859.72%36.55M | 106.47%7.64M | 215.51%1.75M | -44.57%3.42M | -748.88%-4.81M | -53.93%3.7M | -587.17%-1.52M | 6.78%6.17M | -79.78%741.51K |
Earning before tax | 2.48%1.82B | 3.57%6.79B | 1.96%5.2B | 3.02%3.53B | 4.42%1.78B | 12.34%6.56B | 10.77%5.1B | 7.19%3.43B | 7.91%1.7B | 5.61%5.84B |
Tax | ---- | 2.56%-1.27B | 9.47%-952.92M | 7.03%-664.89M | ---- | -11.66%-1.31B | -11.10%-1.05B | -10.51%-715.17M | -13.71%-343.29M | -5.83%-1.17B |
After-tax profit from continuing operations | 3.87%1.48B | 11.25%5.52B | 4.93%4.25B | 13.42%2.87B | 4.71%1.42B | 13.37%4.96B | 10.68%4.05B | -0.92%2.53B | 6.53%1.36B | -1.03%4.37B |
After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | -0.36%290.4M | ---- | --185.4M | ---- | --291.46M |
Special items of earning after tax | -3.12%343.47M | ---- | ---- | ---- | --354.54M | ---- | ---- | ---- | ---- | ---- |
Earning after tax | 2.48%1.82B | 5.10%5.52B | 4.93%4.25B | 5.67%2.87B | 30.84%1.78B | 12.51%5.25B | 10.68%4.05B | 6.35%2.71B | 6.53%1.36B | 5.56%4.67B |
Minority profit | -1.74%159.12M | -17.67%594.34M | -23.23%461.36M | -24.21%303.98M | -24.62%161.93M | 5.54%721.9M | 7.23%600.96M | 8.19%401.06M | 17.11%214.82M | 18.24%683.99M |
Special items of profit attributable to shareholders | -3.12%343.47M | ---- | ---- | ---- | --354.54M | ---- | ---- | ---- | ---- | ---- |
Profit attributable to shareholders | 4.60%1.32B | 8.72%4.92B | 9.83%3.79B | 10.85%2.56B | 10.23%1.26B | 13.71%4.53B | 11.30%3.45B | 6.04%2.31B | 4.75%1.14B | 3.65%3.98B |
Basic earnings per share | 5.26%0.2 | 8.57%0.76 | 9.43%0.58 | 8.33%0.39 | 5.56%0.19 | 14.75%0.7 | 10.42%0.53 | 5.88%0.36 | 5.88%0.18 | 3.39%0.61 |
Diluted earnings per share | 5.26%0.2 | 8.57%0.76 | 9.43%0.58 | 8.33%0.39 | 5.56%0.19 | 14.75%0.7 | 10.42%0.53 | 5.88%0.36 | 5.88%0.18 | 3.39%0.61 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data